Scrip
Lilly issues "Dear Doctor" letter over risks of Zyprexa in adolescents
02 February 2010
Katie McQue
Please Login to read the full article.
02 February 2010
Katie McQue
Lilly has issued a "Dear Doctor" letter regarding the use of its atypical antipsychotic Zyprexa (olanzapine) in adolescents to warn of the increased risk of weight gain and hyperlipidemia compared with its use in adults.
Zyprexa, a dopamine, serotonin and muscarinic receptor antagonist,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US panel to review paediatric use of three antipsychotics
- Seroquel collects more approvals, and a complete response letter, from the US FDA
- Schering-Plough's Saphris approved for schizophrenia and bipolar disorder in the US
- US panel endorses Schering-Plough's antipsychotic asenapine
COMMENT
Other Informa Comment
EVENTS
Today
Cambridge, UK
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
